Whilst complex and time-consuming, the development of new vaccines is one of the most successful and cost-effective public health tools for disease prevention. The TRANSVAC2 Consortium will be delivering several training modules in vaccine R&D in September 2019 in France.  The (extended) deadline for application submission is Saturday June 1.
Apply now - 4th Call for TRANSVAC2 Training Modules: 
More information on the call and the application form can be found here.
M6 - CyTOF (Cytometry by time‐of‐flight)
Description: Cytometry by time‐of‐flight (CyTOF), or mass cytometry, allows the simultaneous detection of multiple phenotypic markers at the single cell level by making use of antibodies and specific probes conjugated with pure heavy metal isotopes.  You can learn a theory and practice of mass-cytometry applied to assessing the immune response in human and animal models.
Venue: CEA, Fontenay-aux-Roses, France  Date: 19-20 September 2019
M7 - Flow Cytometry
Description: The course includes approaches to master multi-dimensional flow cytometry from the basic theory to data analysis, and biological interpretation of the results.
Venue: CEA, Fontenay-aux-Roses, France  Date: 18-19 September 2019
M9 – Process development, scale up of viral vaccines
Description: Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies.
Venue: Merck/M Lab, Molsheim, France  Date: 10-11 September 2019
Deadline for applications to be submitted: 1st June 2019 
Notification of application outcome: 1st July 2019
Applicants can apply for all training via one application form!
More information on the call and the application form can be found here.
For training related information please contact the TRANSVAC team (transvacinfo@euvaccine.eu).


Please Sign in (or Register) to view further.